Purpose: To investigate the trends and progresses in glaucoma research by searching two
major clinical trial registries; clinicaltrials. gov, and Australianclinicaltrials. gov. au. Methods …

Introduction: The main role of preservatives in eyedrops is to ensure sterility and
microbiological integrity of the drug, and to facilitate the penetration of active compounds …

AIM To assess the inflammatory cytokines expression in aqueous humor in diabetic primary
open angle glaucoma (POAG) patients. METHODS A cross-sectional study on 87 eyes …

Ophthalmic formulations have enormous applications in treating several ocular disorders.
Principally, the ocular formulations must be sterile. Hence, preservatives are conventionally …

Purpose To determine variations in cytokine levels of glaucoma patients treated either with
preservative-free latanoprost or preserved latanoprost, relative to healthy individuals …

Glaucoma is treated by frequent instillation of 0.2% w/v brimonidine tartrate eye drop
solution, which showed poor ocular bioavailability of 1–3%. Medicated contact lenses can …

Success of the long-term glaucoma therapy and preservation of the visual function strongly
depend on patients' compliance which may be affected by the inconvenience of treatment …

Objectives: To analyse drug development for open-angle glaucoma during the last 20 years.
Methods: Research was performed by referring to clinical trials registered at the International …

Introduction The purpose of this study is to assess the real-life efficacy and tolerance of a
new preservative-free, surfactant-free latanoprost (PFSF-LAT) formulation. Methods …

Purpose: To report clinical manifestations of ocular allergy to atropine eye drops used for
retardation of progressive myopia in children. Methods: Myopic children, who developed …